ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Hospice and Palliative Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,869Medicare Part D Prescriptions Filled, Including Refills
$485K Total Retail Price of All Prescriptions
521 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 676 602
LISINOPRIL 546 483
LEVOTHYROXINE SODIUM 423 380
HYDROCHLOROTHIAZIDE 380 343
AMLODIPINE BESYLATE 364 327
OMEPRAZOLE 300 205
METOPROLOL SUCCINATE 271 259
LISINOPRIL-HYDROCHLOROTHIAZIDE 266 213
FUROSEMIDE 262 234
ATENOLOL 232 189
ALLOPURINOL 226 175
LOSARTAN POTASSIUM 220 203
WARFARIN SODIUM 205 195
METFORMIN HCL 205 171
ZOLPIDEM TARTRATE 193 155
ATORVASTATIN CALCIUM 190 161
DOXAZOSIN MESYLATE 179 179
METOPROLOL TARTRATE 167 155
HYDROCODONE-ACETAMINOPHEN 160 102 S3
GLIMEPIRIDE 148 121
PRAVASTATIN SODIUM 147 101
SERTRALINE HCL 139 132
CITALOPRAM HBR 138 105
TRAMADOL HCL 116 103
DIGOXIN 116 116
CRESTOR 108 102
POTASSIUM CHLORIDE 107 90
NEXIUM 105 79
LOVASTATIN 101 101
ENALAPRIL MALEATE 100 91
ALENDRONATE SODIUM 96 79
FLUTICASONE PROPIONATE 96 82
CARVEDILOL 95 95
GABAPENTIN 94 89
SPIRIVA 80 56
FLUOXETINE HCL 78 55
SPIRONOLACTONE 77 48
TRIAMTERENE-HCTZ 77 72
PAROXETINE HCL 74 70
FELODIPINE ER 74 74
LOSARTAN-HYDROCHLOROTHIAZIDE 73 73
ADVAIR DISKUS 72 48
TRAZODONE HCL 65 59
NAMENDA 58 58
PREMARIN 56 41 R
ISOSORBIDE MONONITRATE ER 52 51
KLOR-CON M20 52 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.